< Back to previous page
Researcher
Patrick Verschueren
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Skeletal Biology and Engineering Research Center (Division)
Member
From1 Apr 2013 → 30 Sep 2022
Projects
1 - 10 of 13
- Beyond inflammation: addressing disease impact in rheumatoid arthritisFrom1 Oct 2022 → TodayFunding: FWO Strategic Basic Research Grant
- Mass spectrometry based immunoprofiling in rheumatoid arthritis patientsFrom1 Oct 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Implementation of a multimodal screening program for interstitial lung disease in rheumatoid arthritis patientsFrom29 Sep 2021 → TodayFunding: FWO Strategic Basic Research Grant
- Complementarity determining region-based immunoprofiling of rheumatoid arthritis.From1 Jan 2021 → TodayFunding: FWO research project (including WEAVE projects)
- Development and clinical validation of a multiplexed massspectrometry- based assay to improve diagnosis of Rheumatoid ArthritisFrom1 Jan 2021 → 31 Dec 2022Funding: FWO Applied Biomedical Research (TBM)
- How can we optimise the treatment with rituximab for patients with Rheumatoid Arthritis in daily clinical practice?From9 Nov 2020 → 31 Oct 2021Funding: Other federal public and semi-governmental institutions
- Towards a more personalized approach of the ambulatory care for RA patients.From30 Sep 2020 → TodayFunding: FWO Strategic Basic Research Grant
- The Future of Early Rheumatoid Arthritis Management: From Disease Control to Patient WellbeingFrom1 Oct 2018 → 31 Oct 2021Funding: FWO fellowships
- Immuno-profile-directed stratification of patients with rheumatoid arthritisFrom1 Oct 2018 → 30 Sep 2020Funding: IOF - Industrial Research Fund
- Biological characterization of autoantibodies associated with therapy response in rheumatoid arthritisFrom1 Jan 2018 → 31 Dec 2021Funding: FWO research project (including WEAVE projects)
Publications
31 - 40 of 189
- New indicator for discordance between patient-reported and traditional disease activity outcomes in patients with early rheumatoid arthritis(2022)
Authors: Michaël Doumen, Delphine Bertrand, Rene Westhovens, Patrick Verschueren
Pages: 108 - 115 - Tapering of Etanercept is feasible in patients with Rheumatoid Arthritis in sustained remission: a pragmatic randomized controlled trial(2022)
Authors: Delphine Bertrand, Diederik De Cock, Michaël Doumen, Rene Westhovens, Patrick Verschueren
Pages: 470 - 480 - The Effect of Meditation, Mindfulness, and Yoga in Patients with Rheumatoid Arthritis(2022)
Authors: Patrick Verschueren
- Engagement and attrition with eHealth tools for remote monitoring in chronic arthritis: a systematic review and meta-analysis(2022)
Authors: Michaël Doumen, Delphine Bertrand, Rene Westhovens, Patrick Verschueren
- Longitudinal trajectories of fatigue in early RA: the role of inflammation, perceived disease impact and early treatment response(2022)
Authors: Michaël Doumen, Delphine Bertrand, Rene Westhovens, Patrick Verschueren
Pages: 1385 - 1391 - Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the 'JAK-pot' collaboration(2022)
Authors: Patrick Verschueren
Pages: 1358 - 1366 - Undifferentiated arthritis, not just another early manifestation of rheumatoid arthritis(2022)
Authors: Rene Westhovens, Michaël Doumen, Delphine Bertrand, Patrick Verschueren
Pages: 3101 - 3103 - Systematic literature review of observational cohorts and clinical trials into the success rate of glucocorticoid discontinuation after their use as bridging therapy in patients with rheumatoid arthritis(2022)
Authors: Patrick Verschueren, Rene Westhovens
Pages: 937 - 943 - AN ECONOMIC WINDOW OF OPPORTUNITY FOR PATIENTS WITH EARLY RHEUMATOID ARTHRITIS: 5-YEAR COST-EFFECTIVENESS ANALYSIS OF THE CARERA TRIAL(2022)
Authors: Michaël Doumen, Delphine Bertrand, Rene Westhovens, Patrick Verschueren
Pages: 23 - 24 - WHICH FACTORS DRIVE THE CHOICE BETWEEN A 1ST AND 2ND GENERATION TSDMARD THERAPY IN RA THERAPY?(2022)
Authors: Rene Westhovens, Patrick Verschueren
Pages: 359 - 359